Cardio Diagnostics Holdings, Inc. (CDIOW) stock
CDIOWNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as CDIO
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $4.94MP/E –Yield –
Cardio Diagnostics cash
Cash and short-term investments held at the end of each period.
Cardio Diagnostics's cash was $0 at Jun 30, 2026. For fiscal 2025 it was $0, down 100.0% from the year before. The highest annual figure on record is $7.83M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | -100.0% |
| FY2024 | Dec 31, 2024 | $7.83M | +509.8% |
| FY2023 | Dec 31, 2023 | $1.28M | -68.8% |
| FY2022 | Dec 31, 2022 | $4.12M | +703.0% |
| FY2021 | Dec 31, 2021 | $512.77K | +116.3% |
| FY2020 | Dec 31, 2020 | $237.09K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0 | -100.0% |
| Q1 FY2026 | Mar 31, 2026 | $0 | -100.0% |
| Q4 FY2025 | Dec 31, 2025 | $0 | -100.0% |
| Q3 FY2025 | Sep 30, 2025 | $0 | -100.0% |
| Q1 FY2025 | Mar 31, 2025 | $9.69M | +519.8% |
| Q4 FY2024 | Dec 31, 2024 | $7.83M | +509.8% |
| Q3 FY2024 | Sep 30, 2024 | $1.98M | -45.4% |
| Q2 FY2024 | Jun 30, 2024 | $1.31M | -74.0% |
| Q1 FY2024 | Mar 31, 2024 | $1.56M | -76.7% |
| Q4 FY2023 | Dec 31, 2023 | $1.28M | -68.8% |
| Q3 FY2023 | Sep 30, 2023 | $3.63M | -62.4% |
| Q2 FY2023 | Jun 30, 2023 | $5.04M | +1525.9% |
| Q1 FY2023 | Mar 31, 2023 | $6.71M | +1208.2% |
| Q4 FY2022 | Dec 31, 2022 | $4.12M | +42432.0% |
| Q2 FY2022 | Jun 30, 2022 | $9.66M | +28104.5% |
| Q1 FY2022 | Mar 31, 2022 | $310.24K | +30.9% |
| Q4 FY2021 | Dec 31, 2021 | $512.77K | – |
| Q3 FY2021 | Sep 30, 2021 | $9.68K | – |
| Q2 FY2021 | Jun 30, 2021 | $34.25K | – |
| Q4 FY2020 | Dec 31, 2020 | $237.09K | – |